Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany.
Adolescent
Adult
Aged
Cost of Illness
Cost-Benefit Analysis
Dermatitis, Occupational
/ diagnosis
Diagnostic Services
/ economics
Direct Service Costs
Drug Costs
Female
Germany
Humans
Male
Middle Aged
Quality of Life
Severity of Illness Index
Sick Leave
/ economics
Tertiary Prevention
/ economics
Young Adult
cost of illness
cost of intervention
cost-effectiveness
hand eczema
work-related skin disease
Journal
Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
27
12
2019
revised:
21
02
2020
accepted:
24
02
2020
pubmed:
27
2
2020
medline:
16
3
2021
entrez:
27
2
2020
Statut:
ppublish
Résumé
Occupational skin diseases (OSDs) are the most common work-related diseases in Germany and responsible for a large individual and financial burden. Therefore, a tertiary individual prevention program (TIP) is offered to patients with severe OSD who are at increased risk of abandoning their profession. To define cost of illness (COI) of OSD in Germany and to economically evaluate the TIP from a societal perspective. In this study, data on patients taking part in the TIP (September 2005 to December 2009) were collected. Sociodemographic and medical data, costs, disease severity (Osnabrueck Hand Eczema Severity Index), and quality of life (QoL; Dermatology Life Quality Index) were assessed. COI and cost-effectiveness analyses were performed with a simulated control group. In the analysis, 1041 patients were included. Intervention costs per person were €15 009 with decreasing COI over time. The incremental cost-effectiveness ratio revealed expenses per patient of €8942 for a reduction in severity level and €9093 for an improvement in QoL in the base case. Considering costs for retraining, the break-even point is reached if the TIP prevents retraining in approximately 64% of participants. The decreased COI in this long-term evaluation indicates that the TIP is cost-effective in patients with severe OSD.
Sections du résumé
BACKGROUND
BACKGROUND
Occupational skin diseases (OSDs) are the most common work-related diseases in Germany and responsible for a large individual and financial burden. Therefore, a tertiary individual prevention program (TIP) is offered to patients with severe OSD who are at increased risk of abandoning their profession.
OBJECTIVES
OBJECTIVE
To define cost of illness (COI) of OSD in Germany and to economically evaluate the TIP from a societal perspective.
METHODS
METHODS
In this study, data on patients taking part in the TIP (September 2005 to December 2009) were collected. Sociodemographic and medical data, costs, disease severity (Osnabrueck Hand Eczema Severity Index), and quality of life (QoL; Dermatology Life Quality Index) were assessed. COI and cost-effectiveness analyses were performed with a simulated control group.
RESULTS
RESULTS
In the analysis, 1041 patients were included. Intervention costs per person were €15 009 with decreasing COI over time. The incremental cost-effectiveness ratio revealed expenses per patient of €8942 for a reduction in severity level and €9093 for an improvement in QoL in the base case. Considering costs for retraining, the break-even point is reached if the TIP prevents retraining in approximately 64% of participants.
CONCLUSIONS
CONCLUSIONS
The decreased COI in this long-term evaluation indicates that the TIP is cost-effective in patients with severe OSD.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
361-369Subventions
Organisme : The ROQ-Study was funded by German Statutory Accident Insurance (Deutsche Gesetzliche Unfallversicherung [DGUV]) (Reference Number: FB 174).
Informations de copyright
© 2020 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
Références
Rappaport SM. Implications of the exposome for exposure science. J Exposure Sci Environ Epidemiol. 2011;21(1):5-9.
Schulte PA, Pana-Cryan R, Schnorr T, et al. An approach to assess the burden of work-related injury, disease, and distress. Am J Public Health. 2017;107(7):1051-1057.
Bakusic J, Lenderink A, Lambreghts C, et al. Methodologies to Identify Work-Related Diseases: Review of Sentinel and Alert Approaches: European Risk Observatory Literature Review. Luxembourg: Publications Office of the European Union; 2017.
DGUV. Berufskrankheiten. In: Deutsche Gesetzliche Unfallversicherung, ed. Geschäfts- und Rechnungsergebnisse der Gewerblichen Berufsgenossenschaften und Unfallversicherungsträger der Öffentlichen Hand 2017. Paderborn, Germany: Bonifatius GmbH, Druck Buch Verlag; 2018:29-44.
Dickel H, Bruckner T, Bernhard-Klimt C, et al. Surveillance scheme for occupational skin disease in the Saarland, FRG. First report from BKH-S. Contact Dermatitis. 2002;46(4):197-206.
Fowler JF, Ghosh A, Sung J, et al. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol. 2006;54(3):448-457.
Boehm D, Schmid-Ott G, Finkeldey F, et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis. 2012;67(4):184-192.
Matterne U, Apfelbacher CJ, Soder S, et al. Health-related quality of life in health care workers with work-related skin diseases. Contact Dermatitis. 2009;61(3):145-151.
Diepgen TL, Purwins S, Posthumus J, et al. Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational disease. Acta Derm Venereol. 2013;93(5):538-543.
Diepgen TL, Scheidt R, Weisshaar E, et al. Cost of illness from occupational hand eczema in Germany. Contact Dermatitis. 2013;69(2):99-106.
Saetterstrom B, Olsen J, Johansen JD. Cost-of-illness of patients with contact dermatitis in Denmark. Contact Dermatitis. 2014;71(3):154-161.
Blanciforti LA. Economic burden of dermatitis in US workers corrected. J Occup Environ Med. 2010;52(11):1045-1054.
Skudlik C, Wulfhorst B, Bock M, et al. Tertiary individual prevention of occupational skin diseases: a decade's experience with recalcitrant occupational dermatitis. Int Arch Occup Environ Health. 2008;81(8):1059-1064.
Skudlik C, Weisshaar E, Scheidt R, et al. Multicenter study medical-occupational rehabilitation procedure skin-Optimizing and quality assurance of inpatient-management (ROQ). J Dtsch Dermatol Ges. 2009;7(2):122-127.
Skudlik C, Weisshaar E, Scheidt R, et al. First results from the multicentre study rehabilitation of occupational skin diseases - optimization and quality assurance of inpatient management (ROQ). Contact Dermatitis. 2012;66(3):140-147.
Brans R, Skudlik C, Weisshaar E, et al. Multicentre cohort study ‘Rehabilitation of Occupational Skin Diseases-Optimization and Quality Assurance of Inpatient Management (ROQ)’: results from a 3-year follow-up. Contact Dermatitis. 2016;75(4):205-212.
Weisshaar E, Skudlik C, Scheidt R, et al. Multicentre study ‘rehabilitation of occupational skin diseases -optimization and quality assurance of inpatient management (ROQ)’-results from 12-month follow-up. Contact Dermatitis. 2013;68(3):169-174.
Lauer-Fischer GmbH. Lauer Taxe. Webapo InfoSystem, 2017. www.lauer-fischer.de. Accessed February 19, 2020.
Wissenschaftliches Institut der AOK. Anatomisch-Therapeutisch-Chemische Klassifikation mit Tagesdosen: Amtlicher ATC-Index mit DDD-Angaben für Deutschland im Jahre 2012. Heidelberg, Germany: Springer-Verlag; 2012.
Schwabe U, Paffrath D, eds. Arzneiverordnungs-Report 2013: Aktuelle Daten, Kosten, Trends und Kommentare. Heidelberg, Germany: Springer-Verlag; 2013.
Fricke U, Gunther J, Niepraschk-von Dollen K, Zawinell A. Anatomisch-Therapeutischchemische Klassifikation mit Tagesdosen für den deutschen Arzneimittelmarkt: ATC-Index mit DDD-Angaben. Berlin, Germany: Wissenschaftliches Institut der AOK (WIdO) im AOK-Bundesverband GbR; 2018:27-50.
Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9(2):169-180.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216.
Dulon M, Skudlik C, Nübling M, et al. Validity and responsiveness of the Osnabrück Hand Eczema Severity Index (OHSI): a methodological study. Br J Dermatol. 2009;160(1):137-142.
Skudlik C, Dulon M, Pohrt U, et al. Osnabrueck hand eczema severity index-A study of the interobserver reliability of a scoring system assessing skin diseases of the hands. Contact Dermatitis. 2006;55(1):42-47.
Bang H, Zhao H. Median-based incremental cost-effectiveness ratio (ICER). J Stat Theory Pract. 2012;6(3):428-442.
Cortesi PA, Scalone L, Belisari A, et al. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis. 2014;70(3):158-168.
Augustin M, Kuessner D, Purwins S, et al. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. Br J Dermatol. 2011;165(4):845-851.
van der Meer EWC, van Dongen JM, Boot CRL, et al. Economic evaluation of a multifaceted implementation strategy for the prevention of hand eczema among healthcare workers in comparison with a control group: the Hands4u Study. Acta Derm Venereol. 2016;96(4):499-504.
van Gils RF, Bosmans JE, Boot CRL, et al. Economic evaluation of an integrated care programme for patients with hand dermatitis. Contact Dermatitis. 2013;69(3):144-152.
Mollerup A, Veien NK, Johansen JD. Effectiveness of the Healthy Skin Clinic-A randomized clinical trial of nurse-led patient counselling in hand eczema. Contact Dermatitis. 2014;71(4):202-214.
Matterne U, Diepgen TL, Weisshaar E. Effects of a health-educational and psychological intervention on socio-cognitive determinants of skin protection behaviour in individuals with occupational dermatoses. Int Arch Occup Environ Health. 2010;83(2):183-189.
Brazier JE, Yang Y, Tsuchiya A, et al. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215-225.
Blome C, Beikert FC, Rustenbach SJ, et al. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities. Arch Dermatol Res. 2013;305(3):197-204.